These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 22613596
1. Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women. Kim KN, Kim KM, Kim BT, Joo NS, Cho DY, Lee DJ. Chin Med J (Engl); 2012 Apr; 125(7):1249-53. PubMed ID: 22613596 [Abstract] [Full Text] [Related]
2. Association of PAI-1 gene promoter 4g/5g polymorphism with plasma PAI-1 activity in Chinese patients with and without hypertension. Jeng JR. Am J Hypertens; 2003 Apr; 16(4):290-6. PubMed ID: 12670745 [Abstract] [Full Text] [Related]
3. Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure. Björck HM, Eriksson P, Alehagen U, De Basso R, Ljungberg LU, Persson K, Dahlström U, Länne T. Am J Hypertens; 2011 Jul; 24(7):802-8. PubMed ID: 21490692 [Abstract] [Full Text] [Related]
4. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G. Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375 [Abstract] [Full Text] [Related]
6. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia]. Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M. Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596 [Abstract] [Full Text] [Related]
12. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients. Wang AY, Poon P, Lai FM, Yu L, Choi PC, Lui SF, Li PK. Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416 [Abstract] [Full Text] [Related]
13. Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion. von Känel R, Maly FE, Frey K, Fischer JE. Ital Heart J; 2003 Nov; 4(11):791-6. PubMed ID: 14699709 [Abstract] [Full Text] [Related]
14. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis. Li YY. PLoS One; 2012 Nov; 7(4):e33511. PubMed ID: 22496752 [Abstract] [Full Text] [Related]
19. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels. Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y. Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442 [Abstract] [Full Text] [Related]